Pharmaceutical Journal Podcast (#PJPod)

There are significant side effects and drug interactions associated with the use of Bruton tyrosine kinase (BTK) inhibitors. This episode of The #PJPod considers the impact these medicines have had on care for patients with B-cell malignancies, by hearing directly from an expert patient before exploring how pharmacists can help patients get the best out of their treatment regimens.

Listen here: https://pharmaceutical-journal.com/article/feature/btk-inhibitors-what-pharmacists-need-to-know

*Supported by BeiGene UK*

 

Latest News

By BOPA on 31st August 2026

🌟 BOPA Advanced Pharmacist Study Day – Elevate Your Practice, Shape Your Career

Are you an oncology or haematology pharmacist with around five or more years of experience — whether Band 7 or Band 8 — and ready to take the next step…

Read article
By BOPA Executive Committee on 31st August 2026

BOPA 2026 Executive Committee Election – One week left to cast your vote

One week left to cast your vote for the BOPA Executive Committee Election. Have your say at BOPA’s future.   In 2026 we received 9 nominations for 6 positions. -Standard…

Read article
By BOPA Executive Committee on 27th August 2026

UK multidisciplinary Consensus Document – Safe Management of Hazardous Medicinal Products in UK Healthcare Settings

We are pleased to jointly publish the new UK multidisciplinary consensus document, Safe Management of Hazardous Medicinal Products in UK Healthcare Settings. Hazardous medicinal products (HMPs) are used across a…

Read article
By BOPA Executive Committee on 24th August 2026

BOPA 2026 Executive Committee Election – Have you cast your vote for your candidates?

Have you cast your vote for the 2026 BOPA Executive Committee Election? In 2026 we received 9 nominations for 6 positions. -Standard Committee Member (6 places available) – VOTING FOR…

Read article